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Pleurotus ostreatoroseus is a Brazilian edible mushroom whose chemical characterization and bioactivity
still remain underexplored. In this study, the hydrophilic and lipophilic compounds as well as the anti-
oxidant, anti-inﬂammatory and antimicrobial activities of formulations (ethanol extracts) prepared with its
fruiting bodies and submerged culture mycelia were compared. The bioactive formulations contain at
least ﬁve free sugars, four organic acids, four phenolic compounds and two tocopherols. The fruiting
body-based formulation revealed higher reducing power, DPPH scavenging activity, β-carotene bleaching
inhibition and lipid peroxidation inhibition in brain homogenates than the mycelium-based preparation,
as well as higher anti-inﬂammatory and antimicrobial activities. The absence of hepatotoxicity was
conﬁrmed in porcine liver primary cells. These functional responses can be related to the levels of bio-
active components including phenolic acids, organic acids and tocopherols.
Introduction
Besides their worldwide-appreciated flavour, mushrooms oﬀer
exceptional nutritional value, with low lipid content and large
amounts of carbohydrates and proteins, in addition to essen-
tial amino acids and fat-soluble vitamins (vitamins A, D, E and
K).1 Moreover, mushrooms are increasingly attractive as func-
tional foods and as potential sources for the development of
new drugs.2
Among the bioactive compounds found in mushrooms,
tocopherols,3 phenolic compounds4 and some organic acids5
have been implicated for their nutraceutical potential6,7 and
bioactivity, including their antioxidant8,9 and antimicrobial10
eﬀects.
Pleurotus is an important genus of basidiomycetes,
especially; those occurring in the subtropics and tropics, which
occupy the third position in the production of edible mush-
rooms.11,12 Pleurotus spp. can be easily cultivated due to their
ability to colonise and degrade a wide variety of substrates
containing cellulose, hemicellulose and lignin, using them in
their own development.12,13 Furthermore, these species have
a quick mycelium growth and fruiting, and a low cost of
culture.14,15 For these reasons, as well as their well-known
nutritional and functional characteristics, Pleurotus spp. have
become very interesting from a commercial point of view.12
Pleurotus ostreatoroseus Singer is an edible Brazilian mush-
room that stands out for its characteristic rosy coloration and
the delightful flavour of its fruiting bodies. It was firstly
described by Singer16 from sample material collected at Dois
Irmãos Park (Brazilian Atlantic Forest), Recife, PE, Brazil. This
species is included among the white rot fungi for its excellent
potential in lignin degradation and is considered an auto-
chthonous mushroom in the tropics; it grows quite well in tro-
pical temperatures.17
Although a few studies have covered the chemical character-
ization and antitumor and immunomodulatory eﬀects of poly-
saccharides isolated from P. ostreatoroseus fruiting bodies,18–20
the chemical elucidation and bioactivity of other molecules,
such as phenolic compounds, still remain unknown.
Regarding antioxidant, anti-inflammatory and anti-
microbial eﬀects of Pleurotus spp., there are some studies with
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(Rumph. ex Fr.), Pleurotus citrinopileatus Singer and Pleurotus
eryngii (DC.) Quél.9,10,21–23 Nevertheless, to the authors’ knowl-
edge, there are no previous reports on antioxidant, anti-inflam-
matory and antimicrobial activities of P. ostreatoroseus.
In the present work, a study was performed with the fruit-
ing body and mycelium of P. ostreatoroseus, by preparing bio-
active formulations (ethanolic extracts) that were further
characterized in terms of hydrophilic and lipophilic com-
pounds. The antioxidant, anti-inflammatory and antimicrobial
potential of the prepared extracts were evaluated and com-
pared, and non-toxicity was confirmed in a primary cell
culture of porcine liver cells.
Experimental
Fruiting body selection and nutritional characterization
Fruiting bodies (basidiocarps) of P. ostreatoroseus were
obtained from a local producer in Maringá, PR, Brazil, in
spring 2014. The fruiting bodies were selected in accordance
with the commercial requirements in Brazil, i.e., before the
rupture of the veil (closed cap), in order to preserve the
sensory characteristics as well as firmness, which also reduces
fragmentation during processing.
The fruiting bodies were nutritionally characterized regard-
ing moisture, proteins, fat, carbohydrates and ash, by using
the standard procedures.24 The crude protein content (N ×
4.38) was estimated by the macro-Kjeldahl method; the crude
fat was determined by extracting a known weight of powdered
sample with petroleum ether, using a Soxhlet apparatus; the
ash content was determined by incineration at 600 ± 15 °C.
Total fibre was determined by enzymatic–gravimetric
method.24 Carbohydrate value was calculated by diﬀerence.
Production of the P. ostreatoroseus mycelia
A commercial isolate of P. ostreatoroseus was obtained from a
local producer. The stock culture was maintained on wheat
bran extract agar slants (Fig. 1) and sub-cultured every month.
The slants were incubated at 28 °C for 7 days and then stored
at 4 °C in a refrigerator for up 30 days. The inocula were pre-
pared by adding actively growing mycelia from a newly pre-
pared slant culture (5 mycelial agar discs with 0.5 cm
diameter) into 50 mL medium in a 250 mL Erlenmeyer flask.
They were incubated for 5 days at 28 °C on a rotary shaker at
160 rpm. The wheat bran extract medium was prepared with
100 g of wheat bran that was boiled in 1 L of distilled water.
The mixture was then filtered in gauze, and mineral solution25
at a final concentration of 2% was added to the filtrate. For the
submerged culture, 150 mL of the same medium was prepared
in a 500 mL flask, and pre-culture broth was inoculated (at
1.0 mL L−1). The flasks were incubated at 28 °C on a rotary
shaker at 160 rpm for up to 7 days. The mycelia were recovered
from the liquid medium by filtration, washed with distilled
water, immediately stored in the freezer and posteriorly freeze-
dried.
Preparation of the bioactive formulations
The extraction procedure followed the methodology proposed
by Carvajal et al.,26 with ethanol chosen as the extractor
solvent due to its low cost, abundance and lower toxicity in
comparison with other organic solvents. Fruiting bodies were
dried and milled to a fine powder (40 mesh) while the pre-
viously freeze-dried mycelia were milled to the same granulo-
metry. The samples (5 g) were extracted by stirring with
100 mL of ethanol 70 : 30 (in water) at 25 °C and at 130 rpm
for 3 h and filtered through Whatman no 1 paper. The extrac-
tion procedure was repeated twice. The combined filtrates
were concentrated with a rotary vacuum evaporator at 40 °C in
order to eliminate the solvent and posteriorly freeze-dry the
formulation. The freeze-dried powders were stored in the
freezer until use. The extraction yield was about 20% for both
basidioma and mycelium samples.
Standards and reagents
Acetonitrile 99.9%, n-hexane 95% and ethyl acetate 99.8%
were of HPLC grade from Fisher Scientific (Lisbon, Portugal).
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic
acid), sugar, organic acid and phenolic compound standards
were from Sigma (St. Louis, MO, USA). Racemic tocol (50 mg
mL−1) and tocopherols, were purchased from Matreya (PA,
USA). 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained from
Alfa Aesar (Ward Hill, MA, USA). Dimethylsulfoxide (DMSO)
Fig. 1 Morphological characteristics of P. ostreatoroseus. (a) Mycelium cultivated on wheat bran extract agar slants. (b) Bottom of the mycelium
plate of ﬁgure a in which the characteristic rosy coloration can be observed. (c) Fruiting bodies of commercial package.
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(Merck KGaA, Germany) was used as a solvent in antimicrobial
assays. Dulbecco’s modified Eagle’s medium, Hank’s balanced
salt solution (HBSS), fetal bovine serum (FBS), L-glutamine,
trypsin-EDTA, penicillin/streptomycin solution (100 U mL−1
and 100 μg mL−1, respectively) were purchased from Gibco
Invitrogen Life Technologies (California, USA). Sulforhoda-
mine B, trypan blue, trichloroacetic acid (TCA) and Tris were
purchased from Sigma Chemical Co. (Saint Louis, USA).
RAW264.7 cells were purchased from ECACC (“European Col-
lection of Animal Cell Culture”) (Salisbury, UK), lipopoly-
saccharide (LPS) from Sigma and DMEM medium from HyClone.
The Griess Reagent System Kit was purchased from Promega,
and dexamethasone from Sigma. Ethanol and all other chemi-
cals were of analytical grade and purchased from common
sources. Water was treated in a Milli-Q water purification
system (TGI Pure Water Systems, Greenville, SC, USA).
Chemical characterization of the P. ostreatoroseus
formulations
Free sugars. The extracts (500 mg) were spiked with the
Internal Standard, IS (raﬃnose, 5 mg mL−1), re-dissolved in
water (5 mL) and successively defatted three times with 10 mL
of ethyl ether. After ethyl ether removal, the residues were fil-
tered through a 0.22 µm disposable LC filter disk and trans-
ferred into an injection vial. Analysis was performed by high
performance liquid chromatography (HPLC). The total system
consisted of an integrated system with a pump (Knauer, Smart-
line system1000, Berlin, Germany), degasser system (Smartline
manager 5000) and an auto-sampler (AS-2057 Jasco, Easton,
MD, USA), coupled to a refraction index detector (RI detector
Knauer Smartline 2300), as previously described by the
authors.27 The chromatographic separation was achieved with
an Eurospher 100-5 NH2 column (4.6 mm × 250 mm, 5 µm,
Knauer) operating at 35 °C (7971R Grace oven). The mobile
phase used was acetonitrile/deionized water, 70 : 30 (v/v) at a
flow rate of 1 mL min−1. Sugar identification was made by
comparing the relative retention times of sample peaks with
standards. Data were analyzed using Clarity 2.4 Software
(DataApex). Quantification was based on the RI signal
response of each standard, using the internal standard (IS,
raﬃnose) method and by using calibration curves obtained
from the commercial standards of each compound. The
results were expressed in mg per g of extract.
Organic acids. The extracts (50 mg) were re-dissolved in
meta-phosphoric acid (2 mL) and subsequently filtered
through Whatman no 4 paper. Organic acids were determined
by ultra-fast liquid chromatography (UFLC, Shimadzu 20A
series, Shimadzu Corporation, Kyoto, Japan) coupled with a
photodiode array detector (PDA) as previously described by the
authors.5 Separation was achieved on a Sphere Clone (Phe-
nomenex) reverse phase C18 column (5 μm, 250 mm × 4.6 mm
i.d) thermostatted at 35 °C. The elution was performed with
3.6 mM sulphuric acid using a flow rate of 0.8 mL min−1. The
organic acids were quantified by comparison of the area of
their peaks recorded at 215 nm with calibration curves
obtained from commercial standards of each compound. The
results were expressed in mg per g of extract.
Phenolic acids. The extracts were re-dissolved in ethanol :
water (20 : 80, v/v) and filtered through a 0.22 µm disposable
LC filter disk for HPLC analysis. Phenolic acid determination
was performed using the UFLC mentioned above, as previously
described by Reis et al.28 Separation was achieved with a
Waters Spherisorb S3 ODS-2 C18, 3 μm (4.6 mm × 150 mm)
column, thermostatted at 35 °C. The solvents used were: (A)
0.1% formic acid in water, (B) acetonitrile. The elution gradi-
ent established was isocratic at 15% B for 5 min, 15% B to
20% B over 5 min, 20–25% B over 10 min, 25–35% B over
10 min, 35–50% B for 10 min, and then re-equilibration of the
column, using a flow rate of 0.5 mL min−1. Double online
detection was carried out in the DAD using 280 nm as the pre-
ferred wavelength and in a mass spectrometer (MS) connected
to a HPLC system via the DAD cell outlet. The phenolic com-
pounds were characterized according to the UV and mass
spectra, retention times, and comparison with authentic stan-
dards. The identified phenolic acids were quantified by com-
parison of the area of their peaks recorded at 280 nm with
calibration curves obtained from commercial standards of
each compound. The results were expressed in µg per g of
extract.
Tocopherols. BHT solution (10 mg mL−1, 100 μL) and IS
solution (tocol 2 μg mL−1, 250 μL) were added to the extracts
(described above) prior to the extraction procedure. The
extracts were homogenized with methanol (4 mL) by vortex
mixing (1 min). Subsequently, hexane (4 mL) was added and
the extracts were again vortex mixed for 1 min. After that, a
saturated NaCl aqueous solution (2 mL) was added, the
mixture was homogenized (1 min), centrifuged (5 min, 4000g)
and the clear upper layer was carefully transferred to a vial.
The sample was re-extracted twice with hexane. The combined
extracts were taken to dryness under a nitrogen stream, re-dis-
solved in 1 mL of hexane, dehydrated with anhydrous sodium
sulfate, filtered through a 0.22 µm disposable LC filter disk,
and transferred into a dark injection vial. Analysis was per-
formed by HPLC (equipment described above), and a fluo-
rescence detector (FP-2020; Jasco) programmed for excitation
at 290 nm and emission at 330 nm, as previously described by
the authors.27 The chromatographic separation was achieved
with a Polyamide II (250 × 4.6 mm) normal-phase column
from YMC Waters operating at 35 °C. The mobile phase used
was a mixture of hexane and ethyl acetate (70 : 30, v/v) at a flow
rate of 1 ml min−1. The compounds were identified by chroma-
tographic comparisons with authentic standards. Quantifi-
cation was based on the fluorescence signal response of each
standard, using the IS (tocol) method and by using calibration
curves obtained from commercial standards of each com-
pound. The results were expressed in μg per g of extract.
Bioactivity of the P. ostreatoroseus formulations
Antioxidant activity. Successive dilutions of the stock solu-
tion were made and used for in vitro assays as described by
Reis et al.,28 to evaluate the antioxidant activity of the samples.
Food & Function Paper
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The sample concentrations (mg mL−1) providing 50% of anti-
oxidant activity or 0.5 of absorbance (EC50) were calculated
from the graphs of antioxidant activity percentages (DPPH,
β-carotene/linoleate and TBARS assays) or absorbance at
690 nm (ferricyanide/Prussian blue assay) against the sample
concentrations. Trolox was used as a positive control.
Ferricyanide/prussian blue assay. The extract solutions with
diﬀerent concentrations (0.5 mL) were mixed with sodium
phosphate buﬀer (200 mmol L−1, pH 6.6, 0.5 mL) and potass-
ium ferricyanide (1% w/v, 0.5 mL). Each mixture was incubated
at 50 °C for 20 min, and trichloroacetic acid (10% w/v, 0.5 mL)
was added. The mixture (0.8 mL) was poured into the 48 wells
plate in addition to deionized water (0.8 mL) and ferric chlor-
ide (0.1% w/v, 0.16 mL), and the absorbance was measured at
690 nm in an ELX800 Microplate Reader (Bio-Tek Instruments,
Inc.; Winooski, VT, USA).
DPPH radical-scavenging activity assay. This methodology
was performed using the Microplate Reader mentioned above.
The reaction mixtures in the 96 well plate consisted of extract
solutions of diﬀerent concentrations (30 μL) and a methanolic
solution (270 μL) containing DPPH radicals (6 × 10−5 mol L−1).
Each mixture was left to stand for 30 min in the dark, and the
absorption was measured at 515 nm. The radical scavenging
activity (RSA) was calculated as a percentage of the DPPH dis-
coloration using the equation: %RSA = [(ADPPH − AS)/ADPPH] ×
100, where AS is the absorbance of the solution containing the
sample, and ADPPH is the absorbance of the DPPH solution.
Inhibition of β-carotene bleaching or β-carotene/linoleate
assay. A solution of β-carotene was prepared by dissolving
β-carotene (2 mg) in chloroform (10 mL). Two milliliters of this
solution were pipetted into a round-bottom flask. The chloro-
form was removed at 40 °C under vacuum and linoleic acid
(40 mg), Tween 80 emulsifier (400 mg), and distilled water
(100 mL) were added to the flask with vigorous shaking. Ali-
quots (4.8 mL) of this emulsion were transferred into test
tubes containing extract solutions at diﬀerent concentrations
(0.2 mL). The tubes were shaken and incubated at 50 °C in a
water bath. As soon as the emulsion was added to each tube,
the zero time absorbance was measured at 470 nm. β-Carotene
bleaching inhibition was calculated using the following
equation: (Absorbance after 2 h of assay/initial absorbance) × 100.
Thiobarbituric acid reactive substances (TBARS) assay. Porcine
(Sus scrofa) brains were obtained from oﬃcially slaughtered
animals, dissected, and homogenized with Polytron in an ice
cold Tris-HCl buﬀer (20 mM, pH 7.4) to produce a 1 : 2 w/v
brain tissue homogenate which was centrifuged at 3000g for
10 min. An aliquot (100 μL) of the supernatant was incubated
with the diﬀerent concentration sample solutions (200 μL) in
the presence of FeSO4 (10 mM; 100 μL) and ascorbic acid
(0.1 mM; 100 μL) at 37 °C for 1 h. The reaction was stopped by
the addition of trichloroacetic acid (28% w/v, 500 μL), followed
by thiobarbituric acid (TBA, 2%, w/v, 380 μL), and the mixture
was then heated at 80 °C for 20 min. After centrifugation at
3000g for 10 min to remove the precipitated protein, the color
intensity of the malondialdehyde (MDA)-TBA complex in the
supernatant was measured by its absorbance at 532 nm. The
inhibition ratio (%) was calculated using the following
formula: Inhibition ratio (%) = [(A − B)/A] × 100%, where A and
B are the absorbances of the control and the sample solution,
respectively.
Anti-inflammatory activity. The extracts were dissolved in
water, initially concentrated at 8 mg mL−1 and then further
dilutions were prepared from 8 mg mL−1 to 0.125 mg mL−1.
The mouse macrophage-like cell line RAW264.7 was cultured
in DMEM medium supplemented with 10% heat-inactivated
fetal bovine serum and glutamine at 37 °C under 5% CO2, in
humidified air. For each experiment, cells were detached with
a cell scraper. Under our experimental cell density (5 × 105
cells per mL), the proportion of dead cells was less than 1%,
according to Trypan blue dye exclusion tests. Cells were seeded
in 96-well plates at 150 000 cells per well and allowed to attach
to the plate overnight. Then, cells were treated with the
diﬀerent concentrations of each of the extracts for 1 h. Dexa-
methasone (50 µM) was used as a positive control for the
experiment. The following step was stimulation with LPS (1 µg
mL−1) for 18 h. The eﬀect of the tested samples in the absence
of LPS was also evaluated, in order to observe if they induced
changes in NO basal levels. In negative controls, no LPS was
added. Both extracts and LPS were dissolved in supplemented
DMEM. For the determination of nitric oxide, a Griess Reagent
System kit (Promega) was used, which contains sulfanilamide,
NED and nitrite solutions. One hundred microliters of each
cell culture supernatant were transferred to the plate in dupli-
cate and mixed with sulfanilamide and NED solutions, for
5–10 minutes each, at room temperature. The nitrite produced
was determined by measuring the optical density at 515 nm,
in the microplate reader referred to above, and was compared
to the standard calibration curve.
Antibacterial activity. The following Gram-negative bacteria:
Escherichia coli (ATCC 35210), Pseudomonas aeruginosa (ATCC
27853), Salmonella typhimurium (ATCC 13311), Enterobacter
cloacae (ATCC 35030), and Gram-positive bacteria: Staphylo-
coccus aureus (ATCC 6538), Bacillus cereus (clinical isolate), Micro-
coccus flavus (ATCC 10240), and Listeria monocytogenes (NCTC
7973) were used. The microorganisms were obtained from the
Mycological laboratory, Department of Plant Physiology, Insti-
tute for biological research “Siniša Stanković”, University of
Belgrade, Serbia.
The minimum inhibitory (MIC) and minimum bactericidal
(MBC) concentrations were determined by the microdilution
method.29 Each fresh overnight culture of bacteria was
adjusted spectrophotometrically to a concentration of 1 × 105
CFU mL−1. The requested CFU mL−1 corresponded to a bac-
terial suspension determined in a spectrophotometer at
625 nm (OD625). Dilutions of inocula were cultured on solid
medium to verify the absence of contamination and check the
validity of each inoculum. Diﬀerent solvent dilutions of the
ethanolic extract were added to the wells containing 100 μL of
Tryptic Soy Broth (TSB) and afterwards, 10 μL of inoculum was
added to all wells. The microplates were incubated for 24 h at
37 °C. The MIC of the samples was detected following the
addition of 40 μL of iodonitrotetrazolium chloride (INT)
Paper Food & Function
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(0.2 mg mL−1) and incubation at 37 °C for 30 min. The lowest
concentration that produced a significant inhibition (around
50%) of the growth of the bacteria in comparison with the
positive control was identified as the MIC. The minimum
inhibitory concentrations (MICs) obtained from the suscepti-
bility testing of various bacteria to tested extracts were deter-
mined also by a colorimetric microbial viability assay based on
the reduction of the INT color and compared with a positive
control for each bacterial strain.30 MBC was determined by
serial sub-cultivation of 10 μL into microplates containing
100 μL of TSB. The lowest concentration that showed no
growth after this sub-culturing was read as the MBC. Standard
drugs, namely streptomycin and ampicillin, were used as posi-
tive controls. 5% DMSO was used as the negative control.
Samples were tested in duplicate and experiments were
repeated three times.
Antifungal activity. For the antifungal bioassays, the follow-
ing microfungi were used: Aspergillus fumigatus (ATCC 1022),
Aspergillus versicolor (ATCC 11730), Aspergillus ochraceus (ATCC
12066), Aspergillus niger (ATCC 6275), Trichoderma viride (IAM
5061), Penicillium funiculosum (ATCC 36839), Penicillium ochro-
chloron (ATCC 9112), and Penicillium verrucosum var. cyclopium
(food isolate). The organisms were obtained from the Myco-
logical Laboratory, Department of Plant Physiology, Institute
for Biological Research “Siniša Stanković”, Belgrade, Serbia.
The micromycetes were maintained on malt agar (MA) and the
cultures were stored at 4 °C and sub-cultured once a month.31
The fungal spores were washed from the surface of agar
plates with sterile 0.85% saline containing 0.1% Tween 80
(v/v). The spore suspension was adjusted with sterile saline to
a concentration of approximately 1.0 × 105 in a final volume of
100 µL per well. The inocula were stored at 4 °C for further
use. Dilutions of each inoculum were cultured on solid MA to
verify the absence of contamination and to check the validity
of the inoculum.
Minimum inhibitory concentration (MIC) determination
was performed by a serial dilution technique using 96-well
microtitre plates. The investigated extract was dissolved in a
5% solution of DMSO and added to broth malt medium with a
fungal inoculum. The microplates were incubated for 72 h at
28 °C. The lowest concentrations without visible growth (as
assessed using a binocular microscope) were defined as the
MICs. The minimum fungicidal concentrations (MFCs) were
determined by serial sub-cultivation of 2 µL in microtitre
plates containing 100 µL of malt broth per well and further
incubation for 72 h at 28 °C. The lowest concentration with no
visible growth was defined as the MFC, indicating 99.5%
killing of the original inoculum. 5% DMSO was used as a
negative control, while bifonazole and ketoconazole were used
as positive controls. Samples were tested in duplicate and
experiments were repeated three times.
Toxicity for liver cells. A cell culture was prepared from a
freshly harvested porcine liver obtained from a local slaughter
house. It was designated as PLP2. Briefly, the liver tissues were
rinsed in Hank’s balanced salt solution containing 100 U
mL−1 penicillin and 100 µg mL−1 streptomycin, and divided
into 1 × 1 mm3 explants. Some of these explants were placed in
25 cm3 tissue flasks in DMEM supplemented with 10% fetal
bovine serum, 2 mM nonessential amino acids, 100 U mL−1
penicillin and 100 μg mL−1 streptomycin, and incubated at
37 °C with a humidified atmosphere containing 5% CO2. The
medium was changed every 2 days. Cultivation of the cells was
continued with direct monitoring every 2–3 days using a phase
contrast microscope. Before confluence, cells were sub-cul-
tured and plated in 96-well plates at a density of 1.0 × 104 cells
per well, and cultivated in DMEM medium with 10% FBS, 100
U mL−1 penicillin and 100 µg mL−1 streptomycin.32 Cells were
treated for 48 h with the diﬀerent diluted sample solutions
and the same procedure described in the previous section for
the SRB assay was followed. The results were expressed as GI50
values (sample concentrations that inhibited 50% of the net
cell growth). Ellipticine was used as a positive control.
Statistical analysis
Three samples were used and all the assays were carried out in
triplicate. The results are expressed as mean values with stan-
dard deviations (SD). Results were compared by means of a
Student’s t-test to determine the significant diﬀerence among
samples, with p ≤ 0.05. The analysis was carried out using the
SPSS v. 22.0 program (IBM Corp., Armonk, NY, USA).
Results and discussion
Chemical characterization of the P. ostreatoroseus
formulations
The P. ostreatoroseus fruiting body was nutritionally character-
ized and the results are presented in Table 1. The sample
showed regular contents of moisture and ash, besides an
exceptional content of total fibre. The basidioma also pre-
sented a high content of protein and low fat levels. Patil et al.33
reported a similar value of protein content (21 g/100 g) for
Pleurotus ostreatus. Fernandes et al.12 found very distinct nutri-
tional values referring to protein and carbohydrate contents
for P. ostreatus, but similar results referring to moisture and
ash contents.
The herein characterized fruiting bodies and the mycelia
produced by submerged culture were subjected to an ethanolic
extraction in order to prepare bioactive formulations, which
were characterized in terms of hydrophilic and lipophilic com-
pounds (Table 2). Regarding the free sugar composition, it was
Table 1 Nutritional characterization of P. ostreatoroseus fruiting bodies
expressed on a dry weight basis (mean ± SD)
P. ostreatoroseus
fruiting bodies
Fat (g/100 g) 3.0 ± 0.1
Proteins (g/100 g) 26.0 ± 0.2
Ash (g/100 g) 7.6 ± 0.1
Carbohydrates (g/100 g) 18.4 ± 0.1
Total fibre (g/100 g) 45.0 ± 0.2
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possible to quantify five distinct compounds, namely fructose,
mannitol, sucrose, trehalose, and melezitose (Fig. 2). The
mycelium-based formulation revealed higher contents of all
identified sugars than the basidioma-based preparation, with
a total content of free sugars more than 2-fold higher. This
notable diﬀerence between the total sugar content presented
by the studied formulations could be explained, among other
reasons, by the utilization of a sugar-rich wheat bran extract
medium to produce the mycelium biomass. Once it is imposs-
ible to eliminate all the sugar provided by the culture medium
through the filtration and washing processes previously
described, the mycelium sample might have assimilated some
free sugars from the medium. Reis et al.27 reported lower con-
tents of fructose (0.1 ± 0.00 mg g−1 extract and 0.3 ± 0.00 mg
g−1 extract) and mannitol (5.4 ± 0.04 mg g−1 extract and 6.0 ±
0.00 mg g−1 extract) for ethanolic extracts of Pleurotus ostreatus
and Pleurotus eryngii, respectively. These authors also found a
lower content of sucrose (0.3 ± 0.00 mg g−1 extract) in the etha-
nolic extract of P. eryngii. Beluhan and Ranogajec34 reported a
much higher content of mannitol (98.20 ± 0.55 mg g−1 extract)
and a similar content of trehalose (17.9 ± 0.12 mg g−1 extract)
for an ethanolic extract prepared from basidiomas of
P. ostreatus.
It was possible to quantify four diﬀerent organic acids
(Table 2), namely oxalic, malic, citric and fumaric acids. The
mycelium-based formulation revealed the highest concen-
tration of oxalic acid, while the fruiting body-based formu-
lation presented the highest contents of malic and citric acids.
Fumaric acid was only found in the fruiting body extract,
which also presented the highest content of total organic
acids. The profile of organic acids described by Fernandes
et al.12 for P. ostreatus was slightly diﬀerent, since the authors
detected quinic instead of malic acid.
The prepared formulations revealed the presence of
p-hydroxybenzoic, cis p-coumaric and trans p-coumaric acids,
as well as cinnamic acid (Table 2). p-Hydroxybenzoic, cis p-cou-
maric and trans p-coumaric acids were only found in the fruit-
ing body-based formulation. Cinnamic acid was found in both
formulations, although the fruiting body extract had much the
higher content of this compound. The fruiting body-based for-
mulation was clearly richer in phenolic acids compared with
the mycelium-based one. Reis et al.28 also reported the pres-
ence of p-hydroxybenzoic in the basidioma and mycelium of
Table 2 Chemical characterization of P. ostreatoroseus fruiting body-
and mycelium-based formulations (mean ± SD)
Free sugars
Fruiting
body Mycelium
t-Students
test p-value
Fructose 0.46 ± 0.05 10 ± 1 <0.001
Mannitol 12.0 ± 0.1 15 ± 1 0.006
Sucrose 0.84 ± 0.09 10 ± 1 <0.001
Trehalose 10.3 ± 0.5 15.6 ± 0.3 <0.001
Melezitose 2.44 ± 0.03 7.5 ± 0.4 <0.001
Total (mg g−1 extract) 26.0 ± 0.3 58 ± 3 <0.001
Organic acids
Oxalic acid 12 ± 1 39 ± 6 <0.001
Malic acid 95 ± 1 52 ± 1 <0.001
Citric acid 101 ± 26 0.063 ± 0.002 <0.001
Fumaric acid 4.14 ± 0.01 nda —
Total (mg g−1 extract) 212 ± 25 91 ± 8 <0.001
Phenolic compounds
p-Hydroxybenzoic acid 0.129 ± 0.001 nd —
cis p-Coumaric acid 0.03 ± 0.01 nd —
trans p-Coumaric acid 0.032 ± 0.003 nd —
Cinnamic acid 0.050 ± 0.002 0.0065 ± 0.0005 <0.001
Total (µg g−1 extract) 0.24 ± 0.01 0.0065 ± 0.0005 <0.001
Tocopherols
α-Tocopherol 0.08 ± 0.00 0.09 ± 0.01 0.083
β-Tocopherol 0.45 ± 0.02 0.41 ± 0.01 0.026
Total (µg g−1 extract) 0.53 ± 0.02 0.50 ± 0.01 0.044
a nd – not detected.
Fig. 2 Individual proﬁles of P. ostreatoroseus fruiting body (––) and mycelium (—) with regard to sugars: 1 – fructose, 2 – mannitol, 3 – sucrose,
4 – trehalose, 5 –melezitose, 6 – raﬃnose (IS) and MP –mobile phase.
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P. ostreatus (1.56 ± 0.06 and 0.05 ± 0.00 l µg g−1 dw, respect-
ively), as well as cinnamic acid (0.23 ± 0.02 and 9.65 ± 0.86 µg
g−1 dw, respectively).
α-Tocopherol and β-tocopherol were found in both formu-
lations, with no statistical diﬀerences in the contents of each
of these compounds. These two vitamers of tocopherols were
also present in the profile of Pleurotus species reported by
Reis et al.27 and Lin et al.21
Bioactivity of the P. ostreatoroseus formulations
The fruiting body-based formulation revealed higher reducing
power, DPPH scavenging activity, β-carotene bleaching inhi-
bition and lipid peroxidation inhibition in brain homogenates
than the mycelium-based preparation (Table 3). Reis et al.28
reported lower reducing power (EC50 values = 3.31 ± 0.03 mg
mL−1 and 3.72 ± 0.09 mg ml−1, respectively), DPPH scavenging
activity (6.54 ± 0.16 mg mL−1 and 8.67 ± 0.12 mg mL−1,
respectively), β-carotene bleaching inhibition (EC50 values =
2.74 ± 0.16 mg mL−1 and 4.68 ± 0.60 mg mL−1, respectively)
and TBARS formation inhibition (EC50 values 2.58 ± 0.86 mg
mL−1 and 3.95 ± 0.58 mg mL−1, respectively) for methanolic
extracts prepared from basidiomas of P. ostreatus and
P. eryngii. Regarding the DPPH scavenging activity, Tsai et al.35
reported lower activity in ethanolic extracts of P. ostreatus from
Taiwan (5.58 ± 0.24 mg mL−1). Also, the P. ostreatoroseus
mycelium ethanolic extract studied herein had higher DPPH
scavenging activity than the P. ostreatus and P. eryngii mycelia
methanolic extracts (EC50 values 58.13 ± 3.02 mg mL
−1 and
25.40 ± 0.33 mg mL−1, respectively28). The studied ethanolic
preparation revealed lower lipid peroxidation inhibition
measured by the TBARS assay than the mycelium methanolic
extract of P. ostreatus (EC50 value = 1.08 ± 0.86 mg mL
−1),
but a much higher inhibition than the mycelium extract of.
P. eryngii (EC50 value = 21.03 ± 0.45 mg mL
−1), as reported by
Reis et al.28
P. ostreatoroseus formulations revealed a dose-dependent
potential anti-inflammatory activity (Fig. 3), with a relevant
decrease of NO production even in the presence of lower con-
centration extracts (up to 400 µg mL−1). The fruiting body-
based formulation revealed higher activity (lower EC50 value)
than the mycelium-based preparation (Table 3). Moro et al.36
investigated the anti-inflammatory activity of a methanolic
extract of P. ostreatus in LPS-activated macrophages and
reported no anti-inflammatory activity. Nonetheless, Lin
et al.21 reported anti-inflammatory eﬀects of ethanolic extracts
from P. eryngii fruiting bodies and correlated these eﬀects with
their contents of antioxidant components. Thus, the higher
anti-inflammatory activity revealed by the fruiting body-based
formulation, when compared to the correspondent mycelium-
based preparation, may be justified by its higher contents of
hydrophilic and lipophilic antioxidant compounds, including
phenolic acids, as also due to its higher antioxidant capacity.
In fact, oxidative stress caused by the production of nitric
oxide (NO) during inflammation processes has been related to
the occurrence of several diseases such as cancer, diabetes,
renal disease and arthritis.37,38 The elimination of NO by NO
scavengers or the inhibition of its production by iNOS inactiva-
tor alleviates these illness conditions. Thus, the scavenging of
NO or suppression of NO production by iNOS are clearly prom-
ising indices in the screening of new functional foods.39,40
The studied bioactive formulations exhibited antibacterial
activity against all bacteria tested (Table 4). The P. ostreatoro-
seus basidioma ethanolic extract presented higher antibacterial
activity than the correspondent mycelium extract against
Staphylococcus aureus, Bacillus cereus, Pseudomonas aeruginosa,
Escherichia coli, Salmonella typhimurium and Enterobacter
cloacae. The basidioma-based formulation also presented an
antibacterial activity similar to the commercial antibiotic
Table 3 Bioactivity of P. ostreatoroseus fruiting body- and mycelium-
based formulations (mean ± SD)a
Fruiting
body Mycelium
t-Students
test p-value
Antioxidant activity (EC50 values, mg mL
−1)
Reducing power 1.79 ± 0.01 nd —
DPPH scavenging activity 4.78 ± 0.02 15.62 ± 0.13 <0.001
β-Carotene beaching
inhibition
0.40 ± 0.01 7.62 ± 0.25 <0.001
TBARS inhibition 0.29 ± 0.00 2.34 ± 0.08 <0.001
Anti-inflammatory activity (EC50 values, µg mL
−1)
NO production 229.75 ± 4.25 261.23 ± 8.44 0.011
Hepatotoxicity (GI50 values, µg mL
−1)
PLP2 growth inhibition >400 >400 —
a Results of antioxidant activity are expressed as EC50 values: sample
concentration providing 50% of antioxidant activity or 0.5 of absorbance
in the reducing power assay. Trolox EC50 values: 41 µg mL
−1 (reducing
power), 42 µg mL−1 (DPPH scavenging activity), 18 µg mL−1 (β-carotene
bleaching inhibition) and 23 µg mL−1 (TBARS inhibition). Results of
anti-inflammatory activity are expressed as EC50 values: sample
concentration providing 50% inhibition in the production of NO.
Dexamethasone EC50 value is 16 µg mL
−1. Results of hepatotoxicity are
expressed as GI50 values: sample concentration providing 50%
inhibition of the net cell growth. Ellipticine GI50 value is 2.3 µg mL
−1.
Fig. 3 Nitric oxide production as a function of concentration of
P. ostreatoroseus fruiting body- (—) and mycelium- (––) based formu-
lations. As the production of nitric oxide is proportional to the inﬂamma-
tory process, a decrease in the nitric oxide concentration corresponds
to potential anti-inﬂammatory activity.
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streptomycin (MIC 0.25 mg mL−1) against Staphylococcus
aureus. Both studied formulations possessed the same activity
against Listeria monocytogenes, and it was only in the case of
Micrococcus flavus that the mycelium-based preparation pre-
sented higher antibacterial activity than the fruiting body-
based formulation. Alves et al.10 reported high antibacterial
activity of an ether extract of Pleurotus pulmonarius against
Staphylococcus aureus. Tambekar et al.41 reported the anti-
microbial ability of ethanolic, methanolic and xylene extracts of
P. pulmonarius against Escherichia coli and Pseudomonas aerugi-
nosa. Sulphated polysaccharides from P. eryngii showed inhi-
bition against Escherichia coli, Staphylococcus aureus and
Listeria monocytogenes.42
Regarding antifungal activity (Table 4), the P. ostreatoroseus
basidioma ethanolic extract presented higher activity than the
correspondent mycelium-based preparation against Aspergillus
versicolor, A. ochracues, A. niger, Trichoderma viride, Penicillium
funiculosum and P. verrucosum. The studied basidioma ethano-
lic extract also presented similar antifungal activity to that of
the commercial antibiotic bifonazole (0.15 mg mL−1) against
Aspergillus ochracues and Trichoderma viride. Both bioactive for-
mulations possessed the same activity against Aspergillus fumi-
gatus. It was only in the case of Penicillium ochrochloron that
the mycelium-based formulation presented higher antifungal
activity than the fruiting body-based preparation. Hearst
et al.43 found no antifungal activity in the aqueous extract of
Pleurotus ostreatus against Aspergillus fumigatus, A. niger and
Penicillium sp. Moreover, Wang et al.44 reported the activity of
an antifungal peptide isolated from Pleurotus eryngii fruiting
bodies and Ngai et al.45 reported antifungal eﬀects of a ribo-
nuclease isolated from basidiomas of P. pulmonarius. In both
cases, the inhibition of mycelium growth was against Fusarium
oxysporum and Mycosphaerella arachidicola.
As the P. ostreatoroseus bioactive formulations displayed
antioxidant, anti-inflammatory and antimicrobial activity, it
was important to guarantee an absence of cytotoxicity against
liver cells, which are considered the best in vitro model for
studies of human cytotoxicity. The studied samples revealed
no toxicity in liver primary culture PLP2, since the GI50 values
obtained were higher than the highest concentration tested
(>400 µg mL−1). The positive control ellipticine gave a GI50 =
2.29 µg mL−1 (Table 3).
Overall, and to the best of our knowledge, this is the first
report of anti-inflammatory properties of P. ostreatoroseus fruit-
ing body and mycelium extracts, and from the results
obtained, a clear anti-inflammatory and antimicrobial poten-
tial of the tested samples can be inferred. Therefore, these for-
mulations can be used to prepare dietary supplements for
nutraceutical purposes.
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Table 4 Antibacterial and antifungal activities of P. ostreatoroseus fruiting body- and mycelium-based formulationsa
Bacteria
Fruiting body Mycelium Streptomycin Ampicillin
MIC/MBC MIC/MBC MIC/MBC MIC/MBC
Staphylococcus aureus 0.30/0.60 0.40/0.75 0.25/0.50 0.10/0.15
Bacillus cereus 0.15/0.30 0.40/0.75 0.05/0.10 0.10/0.15
Listeria monocytogenes 0.60/1.20 0.60/1.20 0.15/0.30 0.15/0.30
Micrococcus flavus 0.60/1.20 0.45/0.60 0.13/0.25 0.10/0.15
Pseudomonas aeruginosa 0.30/1.20 0.60/1.20 0.05/0.10 0.10/0.20
Escherichia coli 0.60/1.20 0.45/0.60 0.05/0.10 0.30/0.50
Salmonella typhimurium 0.15/0.30 0.45/0.60 0.05/0.10 0.15/0.20
Enterobacter cloacae 0.30/0.60 0.60/1.20 0.05/0.10 0.15/0.20
Fungi
Fruiting body Mycelium Bifonazole Ketoconazole
MIC/MFC MIC/MFC MIC/MFC MIC/MFC
Aspergillus fumigatus 0.60/2.40 0.60/3.60 0.15/0.20 0.20/0.50
Aspergillus versicolor 0.30/2.40 0.60/3.60 0.10/0.20 0.20/0.50
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P. verrucosum 0.60/3.60 1.20/2.40 0.10/0.20 0.20/0.30
aMIC – minimum inhibitory concentration; MBC – minimum bactericidal concentration; MFC – minimum fungicidal concentration.
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